D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 70 Citations 17,910 277 World Ranking 1081 National Ranking 15
Medicine D-index 75 Citations 21,342 361 World Ranking 12168 National Ranking 124

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Virus
  • Disease

Pierre Van Damme mainly investigates Vaccination, Immunology, Pediatrics, Virology and Immunogenicity. His research in Vaccination intersects with topics in Booster dose, Antibody, Immunization, Family medicine and Public health. His Pediatrics study incorporates themes from Whooping cough, Young adult, Confidence interval, Hepatology and Prospective cohort study.

His Virology research is multidisciplinary, relying on both Serology, Epidemiology and Double blind. The Reactogenicity research Pierre Van Damme does as part of his general Immunogenicity study is frequently linked to other disciplines of science, such as Virus-like particle, therefore creating a link between diverse domains of science. The concepts of his Hepatitis B study are interwoven with issues in Hepatitis B vaccine, Viral disease, Hepatitis, Disease burden and Hepatitis B virus.

His most cited work include:

  • Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine (1577 citations)
  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study (981 citations)
  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study (436 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Vaccination, Immunology, Pediatrics, Virology and Immunogenicity. His Vaccination research integrates issues from Hepatitis A, Hepatitis B, Internal medicine and Immunization. The study incorporates disciplines such as Hepatitis B vaccine, Hepatitis and Hepatitis B virus in addition to Hepatitis B.

In Pediatrics, Pierre Van Damme works on issues like Epidemiology, which are connected to Public health. Pierre Van Damme specializes in Virology, namely Viral disease. His Immunogenicity study combines topics in areas such as Adverse effect, Randomized controlled trial and Influenza vaccine.

He most often published in these fields:

  • Vaccination (47.13%)
  • Immunology (34.41%)
  • Pediatrics (21.70%)

What were the highlights of his more recent work (between 2018-2021)?

  • Vaccination (47.13%)
  • Immunogenicity (14.71%)
  • Internal medicine (10.72%)

In recent papers he was focusing on the following fields of study:

Pierre Van Damme mainly investigates Vaccination, Immunogenicity, Internal medicine, Antibody and Immunology. His Vaccination research is multidisciplinary, incorporating perspectives in Hepatitis A, Immunization and Pediatrics. The Pediatrics study which covers Epidemiology that intersects with Clinical trial.

Pierre Van Damme works mostly in the field of Immunogenicity, limiting it down to topics relating to Hepatitis B and, in certain cases, Adjuvant and HBsAg, as a part of the same area of interest. His study in Immunology concentrates on Antigen and Immunity. His work carried out in the field of HPV vaccines brings together such families of science as Transmission and Virology.

Between 2018 and 2021, his most popular works were:

  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. (131 citations)
  • The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study (49 citations)
  • Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial (48 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Disease

Pierre Van Damme mainly focuses on Vaccination, Immunology, Antibody, Internal medicine and Immunization. He is studying Tetanus, which is a component of Vaccination. His study in Immunology focuses on Immune system in particular.

Pierre Van Damme combines subjects such as Serotype and Streptococcus pneumoniae with his study of Internal medicine. His studies in Immunization integrate themes in fields like Disease and Diphtheria. His biological study spans a wide range of topics, including Reactogenicity and Immunogenicity.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine

Timo Vesikari;David O Matson;Penelope Dennehy;Pierre Van Damme.
The New England Journal of Medicine (2006)

2144 Citations

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif.
The Lancet Gastroenterology & Hepatology (2017)

1254 Citations

Comprehensive control of human papillomavirus infections and related diseases.

F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki.
Vaccine (2013)

603 Citations

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen.
The Lancet Gastroenterology & Hepatology (2018)

544 Citations

The global impact of vaccination against hepatitis B: a historical overview.

Alessandro R. Zanetti;Pierre Van Damme;Daniel Shouval.
Vaccine (2008)

496 Citations

Knowledge, Attitudes and Practices in Travel-related Infectious Diseases: The European Airport Survey

Koen Iran Herck;Francesco Castelli;Jane Zuckerman;Hans Nothdurft.
Journal of Travel Medicine (2004)

438 Citations

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults

Pierre Van Damme;Froukje Oosterhuis-Kafeja;Marie Van der Wielen;Yotam Almagor.
Vaccine (2009)

402 Citations

Rotavirus disease and vaccination: impact on genotype diversity

Jelle Matthijnssens;Joke Bilcke;Max Ciarlet;Vito Martella.
Future Microbiology (2009)

299 Citations

Rationale for pertussis booster vaccination throughout life in Europe

Fred Zepp;Ulrich Heininger;Jussi Mertsola;Ewa Bernatowska.
Lancet Infectious Diseases (2011)

290 Citations

Hepatitis A booster vaccination: is there a need?

Pierre Van Damme;J Banatvala;O Fay;S Iwarson.
The Lancet (2003)

289 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Pierre Van Damme

Umesh D. Parashar

Umesh D. Parashar

Centers for Disease Control and Prevention

Publications: 222

Jacqueline E. Tate

Jacqueline E. Tate

Centers for Disease Control and Prevention

Publications: 79

Manish M. Patel

Manish M. Patel

Centers for Disease Control and Prevention

Publications: 66

P. Van Damme

P. Van Damme

University of Antwerp

Publications: 63

Jon R. Gentsch

Jon R. Gentsch

National Center for Immunization and Respiratory Diseases

Publications: 63

Roger I. Glass

Roger I. Glass

National Institutes of Health

Publications: 53

Jason Grebely

Jason Grebely

University of New South Wales

Publications: 52

Timo Vesikari

Timo Vesikari

United States Department of Health and Human Services

Publications: 52

Jelle Matthijnssens

Jelle Matthijnssens

Rega Institute for Medical Research

Publications: 51

Mark Jit

Mark Jit

University of London

Publications: 50

Nigel A. Cunliffe

Nigel A. Cunliffe

University of Liverpool

Publications: 49

Carl D. Kirkwood

Carl D. Kirkwood

Bill & Melinda Gates Foundation

Publications: 48

Gregory J. Dore

Gregory J. Dore

University of New South Wales

Publications: 47

Osamu Nakagomi

Osamu Nakagomi

Nagasaki University

Publications: 42

Mark R. Prausnitz

Mark R. Prausnitz

Georgia Institute of Technology

Publications: 40

Krisztián Bányai

Krisztián Bányai

University of Pecs

Publications: 40

Trending Scientists

Michael L. Honig

Michael L. Honig

Northwestern University

Zoe Radnor

Zoe Radnor

The University of Law

Gregory L. Snider

Gregory L. Snider

University of Notre Dame

Donghong Liu

Donghong Liu

Zhejiang University

Philippe Guionneau

Philippe Guionneau

Centre national de la recherche scientifique, CNRS

Joseph M. Fox

Joseph M. Fox

University of Delaware

Yutaka Tokiwa

Yutaka Tokiwa

National Institute of Advanced Industrial Science and Technology

Lasar S. Shvindlerman

Lasar S. Shvindlerman

RWTH Aachen University

Alok Mani Srivastava

Alok Mani Srivastava

General Electric (United States)

Judit Villén

Judit Villén

University of Washington

Sean Nee

Sean Nee

University of Edinburgh

Jennifer A. Pietenpol

Jennifer A. Pietenpol

Vanderbilt University Medical Center

Simon C. Andrews

Simon C. Andrews

University of Reading

Frank F. Furstenberg

Frank F. Furstenberg

University of Pennsylvania

Stephan Collishaw

Stephan Collishaw

Cardiff University

Reuben R. McDaniel

Reuben R. McDaniel

The University of Texas at Austin

Something went wrong. Please try again later.